{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:31:29Z","timestamp":1793331089922,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The 2013\u20132016 West Africa Ebola virus (EBOV) epidemic caused by the EBOV-Makona isolate is the largest and longest recorded to date. It incurred over 28,000 infections and \u223c11,000 deaths. Early in this epidemic, several mutations in viral glycoprotein (A82V), nucleoprotein (R111C), and polymerase L (D759G) emerged and stabilized. <jats:italic>In vitro<\/jats:italic> studies of these new EBOV-Makona isolates showed enhanced fitness and viral replication capacity. However, <jats:italic>in vivo<\/jats:italic> studies in mice and rhesus macaques did not provide any evidence of enhanced viral fitness or shedding. Infection with late isolates carrying or early isolates lacking (early) these mutations resulted in uniformly lethal disease in nonhuman primates (NHPs), albeit with slightly delayed kinetics with late isolates. The recent report of a possible reemergence of EBOV from a persistent infection in a survivor of the epidemic highlights the urgency for understanding the impact of genetic variation on EBOV pathogenesis. However, potential molecular differences in host responses remain unknown. To address this gap in knowledge, we conducted the first comparative analysis of the host responses to lethal infection with EBOV-Mayinga and EBOV-Makona isolates using bivariate, longitudinal, regression, and discrimination transcriptomic analyses. Our analysis shows a conserved core of differentially expressed genes (DEGs) involved in antiviral defense, immune cell activation, and inflammatory processes in response to EBOV-Makona and EBOV-Mayinga infections. Additionally, EBOV-Makona and EBOV-Mayinga infections could be discriminated based on the expression pattern of a small subset of genes. Transcriptional responses to EBOV-Makona isolates that emerged later during the epidemic, specifically those from Mali and Liberia, lacked signatures of profound lymphopenia and excessive inflammation seen following infection with EBOV-Mayinga and early EBOV-Makona isolate C07. Overall, these findings provide novel insight into the mechanisms underlying the lower case fatality rate (CFR) observed with EBOV-Makona compared to EBOV-Mayinga.<\/jats:p>","DOI":"10.3389\/fmicb.2021.714817","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T14:18:46Z","timestamp":1628864326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Transcriptional Analysis of Infection With Early or Late Isolates From the 2013\u20132016 West Africa Ebola Virus Epidemic Does Not Suggest Attenuated Pathogenicity as a Result of Genetic Variation"],"prefix":"10.3389","volume":"12","author":[{"given":"Kevin J.","family":"Maroney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda N.","family":"Pinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhem","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.gene.6364173","article-title":"Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.","volume":"6","author":"Abbas","year":"2005","journal-title":"Genes Immun."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.55","article-title":"Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.","volume":"7","author":"Agrati","year":"2016","journal-title":"Cell Death Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01543-7","article-title":"Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.","volume":"4","author":"Baillet","year":"2021","journal-title":"Commun. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients.","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.","volume":"5","author":"Baize","year":"1999","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/CVI.00733-14","article-title":"Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSV\u0394G\/EBOVgp).","volume":"22","author":"Barrenas","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2015.20.20.21131","article-title":"Genome sequence analysis of Ebola virus in clinical samples from three British healthcare workers, August 2014 to March 2015.","volume":"20","author":"Bell","year":"2015","journal-title":"Euro Surveill."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.4049\/jimmunol.180.6.4058","article-title":"Functional CD8+ T cell responses in lethal Ebola virus infection.","volume":"180","author":"Bradfute","year":"2008","journal-title":"J. Immunol."},{"key":"B9","first-page":"381","article-title":"Outbreak of Ebola viral hemorrhagic fever\u2013Zaire, 1995.","volume":"44","year":"","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B10","first-page":"475","article-title":"Update: outbreak of Ebola viral hemorrhagic fever\u2013Zaire, 1995.","volume":"44","year":"","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B11","article-title":"2021 Democratic Republic of the Congo, North Kivu Province","year":""},{"key":"B12","year":"","journal-title":"History of Ebola Outbreaks: Cases and Outbreaks of EVD by Year"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005645","article-title":"Different features of Vdelta2 T and NK cells in fatal and non-fatal human Ebola infections.","volume":"11","author":"Cimini","year":"2017","journal-title":"PLoS Negl. Trop Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/bioinformatics\/btl056","article-title":"maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments.","volume":"22","author":"Conesa","year":"2006","journal-title":"Bioinformatics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/jir.2014.0227","article-title":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections.","volume":"35","author":"Davidson","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01913-16","article-title":"Functional characterization of adaptive mutations during the West African Ebola virus outbreak.","volume":"91","author":"Dietzel","year":"2017","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.chom.2017.10.011","article-title":"Multi-platform \u2018omics analysis of human Ebola virus disease pathogenesis.","volume":"22","author":"Eisfeld","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-191","article-title":"STEM: a tool for the analysis of short time series gene expression data.","volume":"7","author":"Ernst","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01703-18","article-title":"NK cells accumulate in infected tissues and contribute to pathogenicity of Ebola virus in mice.","volume":"93","author":"Fausther-Bovendo","year":"2019","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever.","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1093\/cid\/ciz678","article-title":"Case fatality ratio estimates for the 2013-2016 West African Ebola epidemic: application of boosted regression trees for imputation.","volume":"70","author":"Forna","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.molmed.2014.01.010","article-title":"The emerging roles of TCF4 in disease and development.","volume":"20","author":"Forrest","year":"2014","journal-title":"Trends Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1093\/bioinformatics\/btw535","article-title":"ImmQuant: a user-friendly tool for inferring immune cell-type composition from gene-expression data.","volume":"32","author":"Frishberg","year":"2016","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0308","article-title":"Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016.","volume":"372","author":"Garske","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.","volume":"393","author":"Gaudinski","year":"2019","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.","volume":"163","author":"Geisbert","year":"","journal-title":"Am. J. Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1093\/infdis\/jiv284","article-title":"Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection.","volume":"212","author":"Geisbert","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event.","volume":"188","author":"Geisbert","year":"","journal-title":"J. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","article-title":"Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.","volume":"75","author":"Gupta","year":"2001","journal-title":"J. Virol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00177-17","article-title":"A polymorphism within the internal fusion loop of the Ebola virus glycoprotein modulates host cell entry.","volume":"91","author":"Hoffmann","year":"2017","journal-title":"J. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1128\/JVI.02171-15","article-title":"Pan-ebolavirus and Pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses.","volume":"90","author":"Holtsberg","year":"2016","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006397","article-title":"Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.","volume":"13","author":"Iampietro","year":"2017","journal-title":"PLoS Pathog."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease.","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B36","article-title":"Understanding Ebola: the 2014 epidemic.","volume":"12","author":"Kaner","year":"2016","journal-title":"Global. Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijantimicag.2016.01.012","article-title":"Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly.","volume":"47","author":"Khachatoorian","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.cell.2020.10.002","article-title":"Single-cell profiling of Ebola virus disease in vivo reveals viral and host dynamics.","volume":"183","author":"Kotliar","year":"2020","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00705-012-1594-2","article-title":"Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.","volume":"158","author":"Kuhn","year":"2013","journal-title":"Arch. Virol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1137-3","article-title":"Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus.","volume":"18","author":"Liu","year":"2017","journal-title":"Genome Biol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599568","article-title":"Ebolavirus: comparison of survivor immunology and animal models in the search for a correlate of protection.","volume":"11","author":"Longet","year":"2020","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06215-z","article-title":"Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.","volume":"9","author":"Madelain","year":"2018","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1128\/JVI.02751-07","article-title":"Endoplasmic reticulum chaperones are involved in the morphogenesis of rotavirus infectious particles.","volume":"82","author":"Maruri-Avidal","year":"2008","journal-title":"J. Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola virus can be effectively neutralized by antibody produced in natural human infection.","volume":"73","author":"Maruyama","year":"1999","journal-title":"J. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.celrep.2018.04.027","article-title":"Recently identified mutations in the Ebola virus-Makona genome do not alter pathogenicity in animal models.","volume":"23","author":"Marzi","year":"2018","journal-title":"Cell Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3201\/eid2110.150259","article-title":"Delayed disease progression in cynomolgus macaques infected with Ebola virus Makona Strain.","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/infdis\/jiu088","article-title":"Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome.","volume":"210","author":"McElroy","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1473-3099(19)30291-9","article-title":"Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the democratic republic of the Congo: a phylogenetic and in vitro analysis.","volume":"19","author":"McMullan","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00597-19","article-title":"Antiviral innate responses induced by VSV-EBOV vaccination contribute to rapid protection.","volume":"10","author":"Menicucci","year":"2019","journal-title":"mBio"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01372","article-title":"Transcriptome analysis of circulating immune cell subsets highlight the role of monocytes in Zaire Ebola virus Makona pathogenesis.","volume":"8","author":"Menicucci","year":"2017","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies.","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1128\/JVI.00543-06","article-title":"Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.","volume":"80","author":"Mohamadzadeh","year":"2006","journal-title":"J. Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq.","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat. Methods"},{"key":"B55","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1086\/514302","article-title":"Ebola outbreak in Kikwit, democratic republic of the Congo: discovery and control measures.","volume":"179","author":"Muyembe-Tamfum","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2011.01.004","article-title":"Densely interconnected transcriptional circuits control cell states in human hematopoiesis.","volume":"144","author":"Novershtern","year":"2011","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1093\/bioinformatics\/btu333","article-title":"Next maSigPro: updating maSigPro bioconductor package for RNA-seq time series.","volume":"30","author":"Nueda","year":"2014","journal-title":"Bioinformatics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1172\/JCI44960","article-title":"Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype.","volume":"121","author":"O\u2019Brien","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape automation: empowering workflow-based network analysis.","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113518","article-title":"The role of molecular chaperones in virus infection and implications for understanding and treating COVID-19.","volume":"9","author":"Paladino","year":"2020","journal-title":"J. Clin. Med."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01995-20","article-title":"Transcriptional analysis of lymphoid tissues from infected nonhuman primates reveals the basis for attenuation and immunogenicity of an Ebola virus encoding a mutant VP35 protein.","volume":"95","author":"Pinski","year":"","journal-title":"J. Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1080\/22221751.2021.1942229","article-title":"Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses.","volume":"10","author":"Pinski","year":"","journal-title":"Emerg. Microbes Infect."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101473","article-title":"To B or Not to B: mechanisms of protection conferred by rVSV-EBOV-GP and the roles of innate and adaptive immunity.","volume":"8","author":"Pinski","year":"2020","journal-title":"Microorganisms"},{"key":"B64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/dna.2017.3639","article-title":"The role of exosomal VP40 in Ebola virus disease.","volume":"36","author":"Pleet","year":"2017","journal-title":"DNA Cell Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"S365","DOI":"10.1093\/infdis\/jiy472","article-title":"Ebola virus VP40 modulates cell cycle and biogenesis of extracellular vesicles.","author":"Pleet","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/22221751.2018.1557988","article-title":"Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells.","volume":"8","author":"Pujhari","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"B67","year":"2015","journal-title":"R: A Language and Environment for Statistical Computing."},{"key":"B68","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1189\/jlb.4RI0316-099RR","article-title":"Molecular mechanisms of Ebola pathogenesis.","volume":"100","author":"Rivera","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data.","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: an R package for \u2018omics feature selection and multiple data integration.","volume":"13","author":"Rohart","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00820-18","article-title":"Growth-adaptive mutations in the Ebola virus makona glycoprotein alter different steps in the virus entry pathway.","volume":"92","author":"Ruedas","year":"2018","journal-title":"J. Virol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00392-17","article-title":"Spontaneous mutation at amino acid 544 of the Ebola virus glycoprotein potentiates virus entry and selection in tissue culture.","volume":"91","author":"Ruedas","year":"2017","journal-title":"J. Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea.","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus.","volume":"29","author":"Sanchez","year":"1993","journal-title":"Virus Res."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-016-0224-2","article-title":"The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review.","volume":"13","author":"Shoman","year":"2017","journal-title":"Global. Health"},{"key":"B76","doi-asserted-by":"publisher","first-page":"S508","DOI":"10.1093\/infdis\/jiy352","article-title":"T-cell receptor diversity and the control of T-cell homeostasis mark Ebola virus disease survival in humans.","author":"Speranza","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1473-3099(20)30736-2","article-title":"Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.","volume":"21","author":"Thom","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1241-0","article-title":"systemPipeR: NGS workflow and report generation environment.","volume":"17","author":"Tw","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/gtc.12463","article-title":"Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.","volume":"22","author":"Ueda","year":"2017","journal-title":"Genes Cells"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09963-y","article-title":"Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.","volume":"7","author":"Versteeg","year":"2017","journal-title":"Sci. Rep."},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42949-6","article-title":"Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants (vol 7, 9730, 2017).","volume":"9","author":"Versteeg","year":"2019","journal-title":"Sci. Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.","volume":"179","author":"Villinger","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00233-4","article-title":"Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.","volume":"5","author":"Wan","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1084\/jem.20032141","article-title":"Role of natural killer cells in innate protection against lethal ebola virus infection.","volume":"200","author":"Warfield","year":"2004","journal-title":"J. Exp. Med."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","author":"Wickham","year":"2009","journal-title":"ggplot2: Elegant Graphics for Data Analysis."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01098-18","article-title":"Naturally occurring single mutations in Ebola virus observably impact infectivity.","volume":"93","author":"Wong","year":"2019","journal-title":"J. Virol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1093\/infdis\/jiw267","article-title":"Pathogenicity comparison between the Kikwit and Makona Ebola virus variants in rhesus macaques.","volume":"214","author":"Wong","year":"2016","journal-title":"J. Infect. Dis."},{"key":"B90","author":"Zhang","year":"2014","journal-title":"2014 Ebola Outbreak - Genome Sequence Variation Analysis."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.714817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T14:18:56Z","timestamp":1628864336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.714817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":91,"alternative-id":["10.3389\/fmicb.2021.714817"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.714817","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"article-number":"714817"}}